[1] ETMINAN M，TAKKOUCHE B，ISORNA F C，et

al. Risk of ischaemic stroke in people with migraine：

systematic review and meta-analysis of observational

studies[J]. BMJ，2005，330（7482）：63.

[2] ABANOZ Y，GULEN ABANOZ Y，GUNDUZ A，

et al. Migraine as a risk factor for young patients

with ischemic stroke：a case-control study[J].

Neurological sciences，2017，38（4）：611-617.

[3] Headache Classification Committee of the

International Headache Society（IHS）. The

International Classification of Headache Disorders，

3rd edition（beta version）[J]. Cephalalgia，2013，33

（9）：629-808.

[4] WOLF M E，SZABO K，GRIEBE M，et al. Clinical

and MRI characteristics of acute migrainous

infarction[J]. Neurology，2011，76（22）：1911-1917.

[5] LAURELL K，ARTTO V，BENDTSEN L，et al.

Migrainous infarction：a Nordic multicenter study[J].

Eur J Neurol，2011，18（10）：1220-1226.

[6] DALKARA T，NOZARI A，MOSKOWITZ M A.

Migraine aura pathophysiology：the role of blood

vessels and microembolisation[J]. Lancet Neurol，2010，9（3）：309-317.

[7] WOLF M E，JAGER T，BAZNER H，et al. Changes

in functional vasomotor reactivity in migraine with

aura[J]. Cephalalgia，2009，29（11）：1156-1164.

[8] WANG S B，LIU K D，YANG Y，et al. Prevalence

and extent of right-to-left shunt on contrastenhanced

transcranial Doppler in Chinese patients

with migraine in a multicentre case-control study[J/

OL]. Cephalalgia，2017，333102417708203. https：//

doi.org/10.1177/0333102417708203.

[9] SCHWEDT T J，DEMAERSCHALK B M，

DODICK D W. Patent foramen ovale and migraine：a

quantitative systematic review[J]. Cephalalgia，2008，

28（5）：531-540.

[10] 武春桃，白晶，郭珍妮，等. 195例正常人右向左分流

发生率及特点的研究[J]. 中国卒中杂志，2014，9（3）：

193-196.

[11] ANDROULAKIS X M，KODUMURI N，

GIAMBERARDINO L D，et al. Ischemic stroke

subtypes and migraine with visual aura in the ARIC

study[J]. Neurology，2016，87（24）：2527-2532.

[12] GUO Z N，XING Y，LIU J，et al. Compromised

dynamic cerebral autoregulation in patients with

a right-to-left shunt：a potential mechanism of

migraine and cryptogenic stroke[J/OL]. PloS one，

2014，9（8）：e104849. https：//doi.org/10.1371/

journal.pone.0104849.

[13] METSO T M，TATLISUMAK T，DEBETTE S，et al.

Migraine in cervical artery dissection and ischemic

stroke patients[J]. Neurology，2012，78（16）：1221-

1228.

[14] DE GIULI V，GRASSI M，LODIGIANI C，et al.

Association Between Migraine and Cervical Artery

Dissection：The Italian Project on Stroke in Young

Adults[J]. JAMA Neurol，2017，74（5）：512-518.

[15] DEBETTE S，KAMATANI Y，METSO T M，et al.

Common variation in PHACTR1 is associated with

susceptibility to cervical artery dissection[J]. Nat

Genet，2015，47（1）：78-83.

[16] TZOURIO C，TEHINDRAZANARIVELO A，

IGLESIAS S，et al. Case-control study of migraine

and risk of ischaemic stroke in young women[J].

BMJ，1995，310（6983）：830-833.

[17] CURTIS K M，MOHLLAJEE A P，PETERSON H B.

Use of combined oral contraceptives among women

with migraine and nonmigrainous headaches：a

systematic review[J]. Contraception，2006，73（2）：

189-194.

[18] CALHOUN A，FORD S，PRUITT A. The impact

of extended-cycle vaginal ring contraception

on migraine aura：a retrospective case series[J]. Headache，2012，2（8）：1246-1253.

[19] CHANG C L，DONAGHY M，POULTER N.

Migraine and stroke in young women：case-control

study. The World Health Organisation Collaborative

Study of Cardiovascular Disease and Steroid

Hormone Contraception[J]. BMJ，1999，318（7175）：

13-18.

[20] SULAK P，WILLIS S，KUEHL T，et al. Headaches

and oral contraceptives：impact of eliminating the

standard 7-day placebo interval[J]. Headache，2007，

47（1）：27-37.

[21] TIMM F P，HOULE T T，GRABITZ S D，et al.

Migraine and risk of perioperative ischemic stroke

and hospital readmission：hospital based registry

study[J/OL]. BMJ，2017，356：i6635. https：//www.

ncbi.nlm.nih.gov/pmc/articles/PMC5225233/.doi：

10.1136/bmj.i6635.

[22] THORLUND K，SUN-EDELSTEIN C，DRUYTS

E，et al. Risk of medication overuse headache

across classes of treatments for acute migraine[J]. J

Headache Pain，2016，17（1）：107.

[23] ROBERTO G，RASCHI E，PICCINNI C，et al.

Adverse cardiovascular events associated with

triptans and ergotamines for treatment of migraine：

systematic review of observational studies[J].

Cephalalgia，2015，35（2）：118-131.

[24] MARTIN V T，GOLDSTEIN J A. Evaluating the

safety and tolerability profile of acute treatments

for migraine[J]. Am J Med，2005，118（Suppl 1）：

36S-44S.

[25] XING Y Q，GUO Y Z，GAO Y S，et al.

Effectiveness and Safety of Transcatheter Patent

Foramen Ovale Closure for Migraine（EASTFORM）Trial[J/OL]. Sci Rep，2016，6：39081. https：//doi.

org/10.1038/srep39081.

[26] DOWSON A，MULLEN M J，PEATFIELD

R，et al. Migraine Intervention With STARFlex

Technology（MIST）trial：a prospective，multicenter，

double-blind，sham-controlled trial to evaluate the

effectiveness of patent foramen ovale closure with

STARFlex septal repair implant to resolve refractory

migraine headache[J]. Circulation，2008，117（11）：

1397-1404.

[27] MATTLE H P，EVERS S，HILDICK-SMITH D，et

al. Percutaneous closure of patent foramen ovale in

migraine with aura，a randomized controlled trial[J].

Eur Heart J，2016，37（26）：2029-2036.

[28] TOBIS J，CHARLES A，SILBERSTEIN S D，et

al. TCT-30 PREMIUM Trial：Double blind study of

percutaneous closure of patent foramen ovale with

the AMPLATZER® PFO Occluder as a treatment

for migraine with or without aura[J/OL]. J Am Coll

Cardio，2015，66（15，Supplement）：B13. https：//

doi.org/10.1016/j.jacc.2015.08.076.

[29] SONDERGAARD L，KASNER S E，RHODES J F，

et al. Patent Foramen Ovale Closure or Antiplatelet

Therapy for Cryptogenic Stroke[J]. N Engl J Med，

2017，377（11）：1033-1042.

[30] MAS J L，DERUMEAUX G，GUILLON B，et al.

Patent Foramen Ovale Closure or Anticoagulation vs.

Antiplatelets after Stroke[J]. N Engl J Med，2017，377

（11）：1011-1021.

[31] SAVER J L，CARROLL J D，THALER D E，et

al. Long-Term Outcomes of Patent Foramen Ovale

Closure or Medical Therapy after Stroke[J]. N Engl J

Med，2017，377（11）：1022-1032.